SCHEMBL29490926

SCHEMBL29490926

Clc1cnc2c(I)n[nH]c2n1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19641301 1.00 GRM4 (0.31) GRM4
SCHEMBL25208146 0.80 GRM4 (0.33) GRM4
SCHEMBL30849114 0.80 GRM4 (0.33) GRM4
SCHEMBL25204873 0.77 GRM4 (0.31) GRM4
SCHEMBL23169547 0.77 ALDH1A1 (0.37) GRM4
SCHEMBL30424529 0.77 GRM4 (0.31) GRM4
SCHEMBL24283772 0.77 KDM4E (0.33) —
SCHEMBL24283777 0.77 GRM4 (0.31) GRM4
SCHEMBL30316949 0.77 GRM4 (0.31) GRM4
SCHEMBL30328027 0.73 GRM4 (0.31) GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4221703-A1 HSD17B13 INHIBITORS AND USES THEREOF FL2022-001, Inc. (US) 2023-08-09 — — EP disclosed
WO-2022072517-A1 HSD17B13 INHIBITORS AND USES THEREOF METACRINE, INC. (US) 2022-04-07 — — WO disclosed
Send feedback